Skip to content

AbCellera Biologics Inc. ABCL Revenue recognized that was included in deferred income at the beginning of the period

Revenue recognized that was included in deferred income at the beginning of the period at other companies

HTF
Heartflow, Inc. Common StockHTFL
$89K+166%
Paycom Software logo
Paycom SoftwarePAYC
$9M-5.3%
ePlus logo
ePlusPLUS
$24M+57.9%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$7.9M+204%
Rackspace Technology, Inc. logo
Rackspace Technology, Inc.RXT
$60.1M+21.2%
Q2 Holdings logo
Q2 HoldingsQTWO
$76.8M+17.4%

Other financials

Income statement

See full
Revenue$8.3M+96.3%
Operating income-$57.5M+8.2%
Net income-$43.2M+5.4%
EPS (diluted)-$0.14+6.7%

Balance sheet

See full
Cash & equivalents$102.1M-44.6%
Total debt$140.2M+107%
Total equity$938.1M-8.3%
Total assets$1.3B-2.8%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$3.8M-64.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$1.72B+59.2%
Enterprise value$1.76B+100.0%
P/S21.7×-25.0×

Profitability

See full
Operating margin-267.6%-120pp
Net margin-181.7%-77.9pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-14.7%-0.8pp
Debt / equity0.1×+0.1×
Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityRevenueRecognized.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s revenue recognized that was included in deferred income at the beginning of the period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbCellera Biologics Inc.'s revenue recognized that was included in deferred income at the beginning of the period?
AbCellera Biologics Inc. (ABCL) reported revenue recognized that was included in deferred income at the beginning of the period of $7.9M in Q1 2026.
How has AbCellera Biologics Inc.'s revenue recognized that was included in deferred income at the beginning of the period changed year-over-year?
AbCellera Biologics Inc.'s revenue recognized that was included in deferred income at the beginning of the period increased by 203.8% year-over-year, from $2.6M to $7.9M.
What is the long-term trend for AbCellera Biologics Inc.'s revenue recognized that was included in deferred income at the beginning of the period?
Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s revenue recognized that was included in deferred income at the beginning of the period has grown at a -3.5% compound annual growth rate (CAGR), from $18.9M to $17.6M.
What does revenue recognized that was included in deferred income at the beginning of the period mean?
The amount of revenue recognized during the period that was previously recorded as a contract liability or deferred revenue. This indicates the pace at which the company is fulfilling its performance obligations to customers.